Skip to main content

Advertisement

SpringerLink
Log in

A regulatory perspective on in vitro diagnostics

  • Commentary
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A major outreach effort is under way that recruits scientific and technological expertise in industry and academia to optimize regulatory decision-making for next-generation diagnostic tests.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tobin, C. Hosp. Management Int. 75–79 (2003).

  2. McGuire, L. Cancer 36, 638–644 (1975).

    Article  CAS  Google Scholar 

  3. Lesko, L. & Woodcock, J. Nat. Rev. Drug Discov. 3, 763–770 (2004).

    Article  CAS  Google Scholar 

  4. http://www.fda.gov/cder/genomics/pharmacoconceptfn.pdf

  5. Lesko, L.J. & Salerno, R.A. Pharmacogenomics 5, 503–505 (2004).

    Article  Google Scholar 

  6. Lesko, L.J. & Salerno, R.A. Pharmacogenomics 5, 25–30 (2004).

    Article  Google Scholar 

  7. Gutman, S. Clin. Chem. 45, 746–749 (1999).

    Article  CAS  Google Scholar 

  8. Lesko, L.J. et al. J. Clin. Pharmacol. 43, 342–358 (2003).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Deputy Commissioner for Medical and Scientific Affairs,

    Scott Gottlieb & Janet Woodcock

  2. Deputy Commissioner for Operations, The US Food and Drug Administration, Rockville, 20857, Maryland, USA

    Scott Gottlieb & Janet Woodcock

Authors
  1. Scott Gottlieb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet Woodcock
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gottlieb, S., Woodcock, J. A regulatory perspective on in vitro diagnostics. Nat Biotechnol 24, 927–929 (2006). https://doi.org/10.1038/nbt0806-927

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0806-927

  • Springer Nature America, Inc.

Search

Navigation